Ucb, Inc., Ucb Pharma Gmbh, Lts Lohmann Therapie-Systeme Ag v. Actavis Laboratories Ut, Inc.

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
June 16, 2023
ERRATA
______________________
Appeal No. 21-1924
UCB, INC., UCB PHARMA GMBH, LTS LOHMANN
THERAPIE-SYSTEME AG,
Plaintiffs-Appellants
v.
ACTAVIS LABORATORIES UT, INC.,
Defendant-Appellee
-------------------------------------------------
Appeal No. 21-2336
UCB, INC., UCB PHARMA GMBH, LTS LOHMANN
THERAPIE-SYSTEME AG,
Plaintiffs-Appellants
v.
MYLAN TECHNOLOGIES INC.,
Defendant-Appellee
______________________
Decided: April 12, 2023
Precedential Opinion
______________________
Case: 21-1924 Document: 72 Page: 1 Filed: 06/16/2023

-- 1 of 2 --

UCB, INC. v. ACTAVIS LABORATORIES UT , INC. 2
Please make the following change to the caption in the
opinion and judgment issued April 12, 2023, and the order
granting an extension of time issued May 8, 2023:1
UCB, INC., UCB PHARMA GMBH, LTS LOHMANN
THERAPIE-SYSTEME AG,
Plaintiffs-Appellants
v.
ACTAVIS LABORATORIES UT, INC.,
Defendant-Appellee
______________________
2021-1924
______________________
Appeal from the United States District Court for the
District of Delaware in No. 1:19-cv-00474-KAJ, Circuit
Judge Kent A. Jordan.
-----------------------------------------------
UCB, INC., UCB PHARMA GMBH, LTS LOHMANN
THERAPIE-SYSTEME AG,
Plaintiffs-Appellants
v.
MYLAN TECHNOLOGIES INC.,
Defendant-Appellee
______________________
2021-2336
______________________
Appeal from the United States District Court for the
District of Vermont in No. 2:19-cv-00128-cr, Judge Chris-
tina Reiss.
1 The originating tribunal information has been cor-
rected to state that Appeal No. 2021-2336 originated from
the United States District Court for the District of Ver-
mont.
Case: 21-1924 Document: 72 Page: 2 Filed: 06/16/2023

-- 2 of 2 --